Nutex Q3 Profit Falls to $40.2M as Hospital Revenue Drops 19.7%
NUTX has more than doubled off its 52-week low of $83.99.
Summary
Nutex reported Q3 2026 net income of $40.2M ($5.71 diluted) on revenue of $217.6M, down from $55.4M and $267.8M a year earlier, while nine-month earnings were lifted by a $52.3M one-time cut in arbitration-related contract services expense.
Key Events · Earnings and Guidance · NUTX
-
Q3 Profit and Revenue Both Decline
Net income attributable to Nutex Health was $40.2M, or $5.71 per diluted share, versus $55.4M and $7.76 a year earlier. Total revenue fell to $217.6M from $267.8M.
-
Hospital Division Revenue Down 19.7%
Hospital division revenue was $209.1M versus $260.2M, a $51.1M decline, which management ties to 2025 catch-up collection data and ineligible-chart reconciliation rather than volume; patient visits rose 18.1%.
-
One-Time $52.3M Arbitration Cost Cut
The HaloMD pay-on-collected amendment and the CMS IDR administrative fee cut from $115 to $15 reduced nine-month contract services expense by $52.3M, adding $25.0M to net income attributable to Nutex Health ($4.83 per diluted share).
-
Cash Rises to $249.9M
Cash and equivalents were $249.9M at September 30, 2026 versus $185.6M at December 31, 2025, after $50.7M of repurchases and earn-out settlements and $52.0M of net distributions to noncontrolling interests.
Analysis · NUTX · Trade & Services
The quarter deteriorated meaningfully from the prior year: revenue fell to $217.6M from $267.8M, and net income attributable to Nutex dropped to $40.2M ($5.71 diluted) from $55.4M ($7.76). Management attributes the revenue decline to 2025 having benefited from catch-up collection data and the reconciliation of ineligible charts, not to a collapse in volume — patient visits actually rose 18.1%. The nine-month picture looks far better only because of a one-time $52.3M reduction in contract services expense from the HaloMD pay-on-collected amendment and the CMS IDR fee cut from $115 to $15, which added $25.0M to net income attributable to Nutex. Strip that out and the underlying earnings trend is down, which is what matters for a company whose valuation rests on out-of-network arbitration economics.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, NUTX was trading at $193.64 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $83.99 to $226.16. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.